FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Review Period Set for Tpoxx Smallpox Drug

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Siga Technologies Tpoxx (tecovirimat monohydrat...

Federal Register

Cutivate Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA determines that Fougera Pharmaceuticals Cutivate (fluticasone propionate) ointment, 0.005%, was not withdrawn from sale f...

Federal Register

Novartis Serentil Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Novartis Serentil (mesoridazine besylate) tablets 10 mg, 25 mg, 50 mg, and 100 mg were not withdrawn from...

Medical Devices

FDA Raises Infection Risk for Reprocessed Urological Endoscopes

FDA calls attention to the risk of infections associated with reprocessed urological endoscopes.

Biologics

J&J Has Hands Full With Troubled Vaccine Contractor

Johnson & Johnson says it is sending quality and compliance experts to its contract manufacturer Emergent Biosolutions after 15 million doses of its C...

Human Drugs

Artificial Intelligence Platform Aiding Drug Reviews: Report

A GCN report says FDA is relying on the Abbyy digital intelligence platform to analyze and summarize drug safety reports.

Medical Devices

Abbott Covid Test EUA Includes Asymptomatic Use

FDA grants Abbott an Emergency Use Authorization for over-the-counter, non-prescription, asymptomatic use of its BinaxNow Covid-19 Ag Self Test for de...

Human Drugs

Apotex Recalls 3 Lots of Guanfacine Extended-Release Tablets

FDA says Apotex is recalling three lots of Guanfacine extended-release tablets after finding contamination in one lot.

Human Drugs

Sanofis Sarclisa Expanded OK in Multiple Myeloma

FDA approves Sanofis Sarclisa (isatuximab) for combination use with carfilzomib and dexamethasone in treating adult patients with relapsed or refracto...

Federal Register

Drug Registration 2016 Rule Corrected

Federal Register notice: FDA corrects an 8/31/2016 amended final rule that listed inaccurate cross-references to FDAs drug establishment registration ...